ATE305941T1 - Impfstoff - Google Patents

Impfstoff

Info

Publication number
ATE305941T1
ATE305941T1 AT00927666T AT00927666T ATE305941T1 AT E305941 T1 ATE305941 T1 AT E305941T1 AT 00927666 T AT00927666 T AT 00927666T AT 00927666 T AT00927666 T AT 00927666T AT E305941 T1 ATE305941 T1 AT E305941T1
Authority
AT
Austria
Prior art keywords
pyogenes
streptococcus
group
polypeptide
seq
Prior art date
Application number
AT00927666T
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Thomas Areschoug
Charlotte Larsson
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Application granted granted Critical
Publication of ATE305941T1 publication Critical patent/ATE305941T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT00927666T 1999-05-05 2000-05-05 Impfstoff ATE305941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9910375.6A GB9910375D0 (en) 1999-05-05 1999-05-05 Vaccine composition
PCT/IB2000/000726 WO2000068259A2 (en) 1999-05-05 2000-05-05 Vaccine

Publications (1)

Publication Number Publication Date
ATE305941T1 true ATE305941T1 (de) 2005-10-15

Family

ID=10852842

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00927666T ATE305941T1 (de) 1999-05-05 2000-05-05 Impfstoff

Country Status (9)

Country Link
US (1) US7220415B1 (de)
EP (1) EP1175437B1 (de)
AT (1) ATE305941T1 (de)
AU (1) AU778526B2 (de)
CA (1) CA2372497A1 (de)
DE (1) DE60022995T2 (de)
ES (1) ES2250131T3 (de)
GB (1) GB9910375D0 (de)
WO (1) WO2000068259A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1490100T3 (da) * 2002-03-28 2012-03-12 Brenntag Biosector As Kombinerede DNA/proteinvaccinepræparater
WO2004018646A2 (en) * 2002-08-26 2004-03-04 Chiron Corporation Conserved and specific streptococcal genomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459503B (sv) 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
JPH03503117A (ja) 1988-02-12 1991-07-18 ハイテク　レセプター　アーベー 免疫グロブリン結合性物質そのサブフラグメント、それらの製造方法、試薬キットおよび免疫グロブリン結合性物質
EP0367890A1 (de) 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, mit Bindungsaktivität für Immunglobulin A sowie dessen Klonierung und Expression
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
WO1994021685A1 (en) 1993-03-19 1994-09-29 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
AU4070097A (en) * 1996-08-16 1998-03-06 Uab Research Foundation, The Mucosal immunogens for novel vaccines
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine

Also Published As

Publication number Publication date
AU4605100A (en) 2000-11-21
US7220415B1 (en) 2007-05-22
WO2000068259A3 (en) 2001-07-12
GB9910375D0 (en) 1999-06-30
AU778526B2 (en) 2004-12-09
ES2250131T3 (es) 2006-04-16
EP1175437B1 (de) 2005-10-05
DE60022995T2 (de) 2006-06-22
DE60022995D1 (de) 2006-02-16
WO2000068259A2 (en) 2000-11-16
CA2372497A1 (en) 2000-11-16
EP1175437A2 (de) 2002-01-30

Similar Documents

Publication Publication Date Title
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
AR018603A1 (es) Un peptido, util para el tratamiento y/o profilaxis de la enfermedad de alzheimer y el sindrome de down, las composiciones farmaceuticas y vacunas que locontienen, el uso de dicho peptido para la preparacion de las composiciones farmaceuticas, una secuencia de aislado de adn, un plasmido o vector vi
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
JP2003500040A5 (de)
BR9915988A (pt) Vacina para peptidase c5a estreptocócica
EE9900343A (et) Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
BR9712970A (pt) Método para produção de vacina para proteção contra virus sincitial respiratório, mistura de proteìna de fusão purificada, composição imunogênica
EP2011510A3 (de) Pharmazeutische Zusammensetzungen, die immunologisch aktive Herpes simplex Virus Proteinfragmente enthalten
EP0090581A3 (de) Kleine, für Maul- und Klauenseuche spezifische Peptide
CA2014033A1 (en) Compositions and treatments for pneumonia in animals
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
AR035077A1 (es) Polipeptidos de neublastina variante, proteinas de fusion, acidos nucleicos, vectores, celulas hospedadoras, metodos para producir dichos polipeptidos, dimeros, conjugados, composiciones farmaceuticas y uso de dichos polipeptidos en la preparacion de medicamentos
DE60136928D1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
FI924457A0 (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
MXPA02005506A (es) Clonacion de un gen que codifica una racemasa de aminoacido derivada de tripanosoma cruzi, y usos del mismo.
HK141594A (en) Peptide fragments of HIV and their use in vaccines and diagnosis
EA200100700A1 (ru) Гены и белки и их применение
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
BR0309491A (pt) Composição de vacina, composição imunogênica, utilização de uma proteìna e7 e anticorpos neutralizantes
HK141494A (en) Peptide fragments of HIV
BR9815496A (pt) Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório
RU93048174A (ru) Авирулентная вакцина против бешенства и способ ее получения
ATE305941T1 (de) Impfstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties